Kyudenko Corp
TSE:1959
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
5 034
7 058
|
Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
Kyudenko Corp
Current Assets | 280.1B |
Cash & Short-Term Investments | 86.6B |
Receivables | 126.2B |
Other Current Assets | 67.2B |
Non-Current Assets | 185.2B |
Long-Term Investments | 77.7B |
PP&E | 78.1B |
Intangibles | 4B |
Other Non-Current Assets | 25.5B |
Current Liabilities | 149.5B |
Accounts Payable | 74.1B |
Other Current Liabilities | 75.5B |
Non-Current Liabilities | 18.4B |
Long-Term Debt | 6.5B |
Other Non-Current Liabilities | 12B |
Balance Sheet
Kyudenko Corp
Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
37 957
|
28 973
|
30 314
|
35 189
|
41 017
|
55 851
|
50 905
|
39 021
|
67 534
|
98 548
|
|
Cash Equivalents |
37 957
|
28 973
|
30 314
|
35 189
|
41 017
|
55 851
|
50 905
|
39 021
|
67 534
|
98 548
|
|
Short-Term Investments |
197
|
307
|
1
|
26
|
20
|
1 007
|
0
|
987
|
0
|
0
|
|
Total Receivables |
79 853
|
90 854
|
106 198
|
127 593
|
150 589
|
139 728
|
130 687
|
136 642
|
148 899
|
164 887
|
|
Accounts Receivables |
79 853
|
90 854
|
106 198
|
127 593
|
150 589
|
139 728
|
130 687
|
136 642
|
148 899
|
164 887
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Inventory |
10 356
|
7 663
|
11 474
|
13 167
|
7 850
|
9 957
|
21 529
|
29 489
|
39 995
|
43 922
|
|
Other Current Assets |
7 421
|
7 945
|
10 185
|
2 909
|
6 792
|
9 726
|
9 453
|
10 840
|
21 792
|
17 061
|
|
Total Current Assets |
135 784
|
135 742
|
158 172
|
178 884
|
206 268
|
216 269
|
212 574
|
216 979
|
278 220
|
324 418
|
|
PP&E Net |
81 571
|
83 279
|
85 762
|
85 164
|
83 750
|
82 625
|
80 698
|
80 844
|
81 745
|
78 667
|
|
PP&E Gross |
81 571
|
83 279
|
85 762
|
85 164
|
83 750
|
82 625
|
80 698
|
80 844
|
81 745
|
78 667
|
|
Accumulated Depreciation |
46 601
|
50 648
|
53 453
|
56 657
|
60 259
|
64 158
|
67 894
|
71 694
|
78 415
|
81 574
|
|
Intangible Assets |
1 190
|
1 012
|
975
|
943
|
986
|
1 466
|
1 729
|
3 613
|
3 457
|
3 883
|
|
Goodwill |
1 408
|
1 556
|
1 175
|
500
|
343
|
182
|
0
|
755
|
821
|
507
|
|
Note Receivable |
297
|
483
|
576
|
932
|
1 179
|
1 209
|
1 256
|
313
|
89
|
14
|
|
Long-Term Investments |
29 768
|
31 953
|
46 897
|
48 675
|
53 928
|
56 107
|
63 194
|
61 175
|
64 494
|
73 645
|
|
Other Long-Term Assets |
4 924
|
8 015
|
6 921
|
9 821
|
10 817
|
10 624
|
7 081
|
14 717
|
17 584
|
22 150
|
|
Other Assets |
1 408
|
1 556
|
1 175
|
500
|
343
|
182
|
0
|
755
|
821
|
507
|
|
Total Assets |
254 942
N/A
|
262 040
+3%
|
300 478
+15%
|
324 919
+8%
|
357 271
+10%
|
368 482
+3%
|
366 532
-1%
|
378 396
+3%
|
446 410
+18%
|
503 284
+13%
|
|
Liabilities | |||||||||||
Accounts Payable |
68 445
|
68 369
|
80 636
|
98 738
|
109 454
|
101 478
|
87 152
|
88 747
|
98 594
|
119 498
|
|
Short-Term Debt |
726
|
396
|
14 839
|
400
|
88
|
30
|
25
|
18
|
1 200
|
1 322
|
|
Current Portion of Long-Term Debt |
2 556
|
2 561
|
6 548
|
8 096
|
2 844
|
2 916
|
2 894
|
7 964
|
2 414
|
28 821
|
|
Other Current Liabilities |
28 605
|
25 719
|
22 722
|
22 988
|
29 758
|
38 299
|
35 290
|
26 717
|
39 483
|
45 886
|
|
Total Current Liabilities |
100 332
|
97 045
|
124 745
|
130 222
|
142 144
|
142 723
|
125 361
|
123 446
|
141 691
|
195 527
|
|
Long-Term Debt |
29 805
|
28 209
|
13 889
|
11 580
|
16 256
|
14 906
|
12 851
|
6 276
|
33 945
|
6 405
|
|
Minority Interest |
2 040
|
2 026
|
1 622
|
2 689
|
1 858
|
1 831
|
1 933
|
2 059
|
2 175
|
2 344
|
|
Other Liabilities |
20 147
|
23 587
|
20 341
|
18 978
|
16 695
|
13 411
|
6 579
|
7 480
|
7 757
|
10 227
|
|
Total Liabilities |
152 324
N/A
|
150 867
-1%
|
160 597
+6%
|
163 469
+2%
|
176 953
+8%
|
172 871
-2%
|
146 724
-15%
|
139 261
-5%
|
185 568
+33%
|
214 503
+16%
|
|
Equity | |||||||||||
Common Stock |
7 901
|
7 901
|
11 632
|
12 555
|
12 561
|
12 561
|
12 561
|
12 561
|
12 561
|
12 561
|
|
Retained Earnings |
85 537
|
101 173
|
119 700
|
139 809
|
159 401
|
177 642
|
195 601
|
214 655
|
233 918
|
253 824
|
|
Additional Paid In Capital |
7 889
|
7 891
|
11 907
|
12 853
|
13 012
|
12 982
|
12 987
|
12 987
|
13 046
|
13 069
|
|
Unrealized Security Profit/Loss |
4 012
|
2 117
|
3 097
|
4 261
|
3 585
|
745
|
3 998
|
1 848
|
2 428
|
7 810
|
|
Treasury Stock |
48
|
611
|
8
|
8
|
10
|
8
|
8
|
9
|
10
|
493
|
|
Other Equity |
2 673
|
7 298
|
6 447
|
8 020
|
8 231
|
8 311
|
5 331
|
2 907
|
1 101
|
2 010
|
|
Total Equity |
102 618
N/A
|
111 173
+8%
|
139 881
+26%
|
161 450
+15%
|
180 318
+12%
|
195 611
+8%
|
219 808
+12%
|
239 135
+9%
|
260 842
+9%
|
288 781
+11%
|
|
Total Liabilities & Equity |
254 942
N/A
|
262 040
+3%
|
300 478
+15%
|
324 919
+8%
|
357 271
+10%
|
368 482
+3%
|
366 532
-1%
|
378 396
+3%
|
446 410
+18%
|
503 284
+13%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
66
|
66
|
70
|
71
|
71
|
71
|
71
|
71
|
71
|
71
|